Please check your internet connection and try again.
# Arsil DX (Dextromethorphan/Chlorpheniramine/Phenylephrine)
## Overview
Arsil DX is a fixed-dose combination product containing an antitussive (dextromethorphan), a first-generation antihistamine (chlorpheniramine), and a sympathomimetic decongestant (phenylephrine). It is indicated for the temporary relief of symptoms associated with the common cold and upper respiratory allergies.
## Primary Indications
Temporary relief of cough, nasal congestion, runny nose, sneezing, and itchy/watery eyes due to the common cold or hay fever.
## Adult Dosing
* **Dosing:** 10 mL orally every 4 to 6 hours as needed.
* **Maximum:** Do not exceed 4 doses (40 mL) in any 24-hour period.
## Pediatric Dosing
* **Children 6 to <12 years:** 5 mL orally every 4 to 6 hours as needed. Maximum 4 doses (20 mL) per 24 hours.
* **Children <6 years:** Use is generally not recommended without physician oversight due to risk of serious adverse events and lack of standardized efficacy.
* *Note: Always use the calibrated measuring device provided with the product.*
## Dose Adjustments
* **Renal/Hepatic Impairment:** No formal standardized adjustments; exercise caution in patients with significant impairment due to potential accumulation of chlorpheniramine and dextromethorphan metabolites. Use with extreme caution in clinical settings where reduced clearance is suspected.
## Contraindications
* Hypersensitivity to any component.
* Current use (or within 14 days) of Monoamine Oxidase Inhibitors (MAOIs).
* Narrow-angle glaucoma, severe hypertension, or severe coronary artery disease.
* Concomitant use of other products containing dextromethorphan or antihistamines.
## Adverse Effects
* **CNS:** Drowsiness (common), dizziness, insomnia, nervousness.
* **Cardiovascular:** Tachycardia, palpitations, elevated blood pressure.
* **Anticholinergic:** Dry mouth, urinary retention, blurred vision, constipation.
* **GI:** Nausea and abdominal discomfort.
## Key Drug Interactions
* **MAOIs:** Risk of hypertensive crisis or serotonin syndrome.
* **CNS Depressants:** Alcohol, sedatives, and hypnotics can cause additive impairment of psychomotor function.
* **Antihypertensives:** Phenylephrine may antagonize the therapeutic effects of blood pressure-lowering medications.
## Monitoring
* Monitor blood pressure periodically if patient has pre-existing cardiovascular history.
* Assess for excessive sedation or paradoxical excitation, particularly in pediatric and geriatric populations.
* Monitor for signs of urinary retention.
## Clinical Pearls
* **Sedation:** Advise patients that chlorpheniramine can cause significant drowsiness; avoid operating heavy machinery.
* **Efficacy Awareness:** The clinical efficacy of oral phenylephrine at standard doses as a nasal decongestant has been formally questioned by recent FDA advisory panels.
* **Avoid Overlap:** Ensure patients are not taking additional OTC cold medications (e.g., Tylenol Cold, NyQuil) to prevent accidental overdose of acetaminophen or repetitive dosing of the same active ingredients.
* **Alcohol:** Explicitly advise against alcohol consumption while taking this medication.
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult the most recent FDA-approved prescribing information, your institution’s clinical guidelines, or a board-certified pharmacist before administering medication, as clinical protocols and safety data may change.